Arkolith/Insider Trading/NAMS/Form 4

Kooij Louise Frederika

Chief Accounting OfficerNewAmsterdam Pharma Co N.V. (NAMS) · full profile →Form 4 · filed Sep 5, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$453K
Net Open-Market Flow
-$453K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 3, 2025Sell(S)18K$25.09$453K15K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-113276) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML